Sunday, December 29, 2019

NuVasive At New Highs As New Management Has Quickly Built Credibility

Companies don’t turn on a dime, and it’s not fair to attribute all of NuVasive’s (NUVA) recent improvements to new management, but there has definitely been a shift at NuVasive – not just in tone and priorities, but in delivered performance as well. With NuVasive not only improving strongly upon its core (the X360 platform) but also expanding into new areas (Pulse Robotics), and showing improved operational execution, it’s no wonder investors have come back to this name. I liked NuVasive in June, and the shares are up about 35% since then, almost quintupling the performance of the larger medical device segment. Although 2019 has developed more or less as I expected from a modeling perspective, I’m more bullish on the company’s near-to-medium-term future. Although the stock already reflects this, this would certainly be a name to reconsider on a pullback.

Read the full article here:
NuVasive At New Highs As New Management Has Quickly Built Credibility

No comments: